Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $14,887,810.00
- $1,037,179,923.19
- March 13, 2026
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 23, 2016 | Director | 5,130 | $81.38 | Sell | $417,479.40 | |
| March 16, 2016 | Director | 5,130 | $79.65 | Sell | $408,604.50 | |
| March 2, 2016 | Director | 5,130 | $91.80 | Sell | $470,934.00 | |
| Feb. 24, 2016 | Director | 5,130 | $85.25 | Sell | $437,332.50 | |
| Feb. 17, 2016 | Director | 5,130 | $86.93 | Sell | $445,950.90 | |
| Feb. 10, 2016 | Director | 5,130 | $82.57 | Sell | $423,584.10 | |
| Feb. 3, 2016 | CFO | 12,084 | $90.84 | Sell | $1,097,710.56 | |
| Feb. 3, 2016 | CEO | 9,834 | $90.82 | Sell | $893,123.88 | |
| Feb. 3, 2016 | Director | 5,130 | $90.81 | Sell | $465,855.30 | |
| Feb. 3, 2016 | SVP | 5,062 | $90.82 | Sell | $459,730.84 | |
| Feb. 3, 2016 | EVP | 6,042 | $90.82 | Sell | $548,734.44 | |
| Feb. 2, 2016 | CMO | 2,375 | $91.38 | Sell | $217,027.50 | |
| Jan. 27, 2016 | Director | 11,200 | $93.22 | Sell | $1,044,064.00 | |
| Jan. 20, 2016 | Director | 10,400 | $93.69 | Sell | $974,376.00 | |
| Jan. 13, 2016 | Director | 10,400 | $98.41 | Sell | $1,023,464.00 | |
| Jan. 6, 2016 | Director | 10,400 | $121.96 | Sell | $1,268,384.00 | |
| Jan. 4, 2016 | Director | 1,125 | $122.21 | Sell | $137,486.25 | |
| Dec. 30, 2015 | Director | 10,400 | $127.15 | Sell | $1,322,360.00 | |
| Dec. 21, 2015 | Director | 10,400 | $119.26 | Sell | $1,240,304.00 | |
| Dec. 9, 2015 | Director | 10,400 | $120.80 | Sell | $1,256,320.00 | |
| Dec. 4, 2015 | EVP | 4,531 | $123.98 | Sell | $561,753.38 | |
| Dec. 2, 2015 | Director | 10,400 | $130.91 | Sell | $1,361,464.00 | |
| Dec. 1, 2015 | Director | 1,125 | $129.65 | Sell | $145,856.25 | |
| Dec. 1, 2015 | EVP | 5,000 | $131.00 | Sell | $655,000.00 | |
| Nov. 23, 2015 | Director | 10,400 | $132.18 | Sell | $1,374,672.00 | |
| Nov. 11, 2015 | Director | 10,400 | $118.59 | Sell | $1,233,336.00 | |
| Nov. 4, 2015 | Director | 10,400 | $124.23 | Sell | $1,291,992.00 | |
| Nov. 2, 2015 | Director | 1,125 | $126.19 | Sell | $141,963.75 | |
| Oct. 28, 2015 | Director | 10,400 | $119.01 | Sell | $1,237,704.00 | |
| Oct. 21, 2015 | Director | 10,400 | $108.82 | Sell | $1,131,728.00 | |
| Oct. 14, 2015 | Director | 10,400 | $112.62 | Sell | $1,171,248.00 | |
| Oct. 7, 2015 | Director | 10,400 | $109.61 | Sell | $1,139,944.00 | |
| Oct. 2, 2015 | Director | 20,000 | $110.00 | Sell | $2,200,000.00 | |
| Oct. 1, 2015 | EVP | 12,417 | $104.71 | Sell | $1,300,184.07 | |
| Oct. 1, 2015 | Director | 1,125 | $104.64 | Sell | $117,720.00 | |
| Sept. 30, 2015 | Director | 10,400 | $103.14 | Sell | $1,072,656.00 | |
| Sept. 23, 2015 | Director | 10,400 | $111.89 | Sell | $1,163,656.00 | |
| Sept. 16, 2015 | Director | 10,400 | $133.24 | Sell | $1,385,696.00 | |
| Sept. 9, 2015 | Director | 10,400 | $131.41 | Sell | $1,366,664.00 | |
| Sept. 4, 2015 | EVP | 9,063 | $125.77 | Sell | $1,139,853.51 | |
| Sept. 2, 2015 | Director | 10,400 | $125.85 | Sell | $1,308,840.00 | |
| Sept. 1, 2015 | Director | 1,125 | $125.40 | Sell | $141,075.00 | |
| Aug. 26, 2015 | Director | 10,400 | $124.71 | Sell | $1,296,984.00 | |
| Aug. 19, 2015 | Director | 10,400 | $139.93 | Sell | $1,455,272.00 | |
| Aug. 12, 2015 | Director | 10,400 | $135.83 | Sell | $1,412,632.00 | |
| July 22, 2015 | Director | 10,400 | $130.92 | Sell | $1,361,568.00 | |
| July 15, 2015 | Director | 12,200 | $133.98 | Sell | $1,634,556.00 | |
| July 13, 2015 | SVP | 1,125 | $123.79 | Sell | $139,263.75 | |
| July 8, 2015 | Director | 11,700 | $122.74 | Sell | $1,436,058.00 | |
| July 2, 2015 | CMO | 2,291 | $129.36 | Sell | $296,363.76 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Amit Sachdev, Jeffrey M Leiden, Michael Parini, David Altshuler, Jeffrey Chodakewitz, Joshua S. Boger, Yuchun Lee, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Bruce I Sachs, Bastiano Sanna, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Kristen Ambrose, Elaine Ullian, Bruce Sachs, Stuart A. Arbuckle, Jonathan Biller, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Jeffrey Leiden, Edward Morrow Atkinson III, Wayne Joseph Riley, Thomas Graney, Mark E Bunnage, Paul Silva, Christiana Stamoulis, Lloyd Carney, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, Kenneth Horton, Paul M. Silva, Ian F. Smith, William D Young, Duncan Mckechnie, and Sangeeta N. Bhatia
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.